Last update July 7, 2022
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Ketamine Hydrochloride in other languages or writings:
Ketamine Hydrochloride belongs to this group or family:
Main tradenames from several countries containing Ketamine Hydrochloride in its composition:
|T½||2.5 - 3.1||hours|
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Ketamine is a fast-acting general anesthetic used for the induction of anesthesia, usually in combination with a muscle relaxant. Intravenous administration.
Since the last update we have not found published data on its excretion in breastmilk.
Its high volume of distribution makes excretion in breast milk unlikely, and its low oral bioavailability minimizes the passage into infant plasma from ingested breast milk.
No problems have been seen in infants whose mothers were treated with ketamine. (Gilder 2021, Ortega 1999)
The use of S-ketamine or Ketamine as post-caesarean analgesia did not affect the duration of breastfeeding (Suppa 2012) and shortened the time to first breastfeeding. (Jaafarpour 2017)
t may be a cause of hallucinatory/psychotic reactions in the mother within the next 24 hours after usage: close follow-up is mandatory. (Pfizer 2020, Vallersnes 2016, Sandoz 2015, OMS 2003)
Several medical societies and expert authors consider the use of this medication possible during breastfeeding. (Howie 2006, WHO 2002)
Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable (Reece 2017), especially during the neonatal period and in the event of prematurity.
See below the information of this related product: